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Given the controversial experimental and clinical data reported in the literature, up
to now it is rather difficult to draw a definitive conclusion on the effects of V1
agonists on splanchnic haemodynamics. Nevertheless, it must be underscored that
most of the experimental studies assessing the effects of low dose V1 agonist
infusion in hyperdynamic models did not demonstrate any detrimental effect on
splanchnic haemodynamics both at macro- and microcirculatory levels.
Interestingly, all the reported studies focused on macro- and microcirculatory
haemodynamics, while only some also addressed the local oxygenation and
metabolism. In clinical studies in patients with septic shock, data are accumulating
regarding the absence of clinically relevant side effects in the splanchnic region
when vasopressin is used, but conversely little is known about the safety of
terlipressin, mainly because of the small number of patients studied. Thus, the
absence of clinically harmful effect does not exclude covert splanchnic ischaemia,
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